23 Jan 2015 07:52
AIM-listed medtech group Angle has signed a collaboration agreement with the University of Southern California (USC) Norris Comprehensive Cancer Center to investigate the clinical use of the Parsortix system for breast cancer. The collaboration follows four months of evaluation by USC Norris of Angl
Read more